Search for: "PAR PHARMACEUTICALS" Results 181 - 200 of 303
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction agains… [read post]
29 Jul 2013, 4:00 am by Administrator
Le Blogue du CRLUne substitution de sûreté peut être obtenue par ordonnance de sauvegardeDans Sarailis c. [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O)   Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
6 Apr 2011, 12:18 am by Marie Louise
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
3 Jun 2014, 2:24 pm by Lebowitz & Mzhen
More Blog Posts: Colorado Man Recovers Over $10 Million in Pharmaceutical Error Case, Pharmacy Error Injury Lawyer Blog, May 7, 2014. [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
  Unjust enrichment of pharmaceutical company towards health insurerMenzis / AstraZeneca, District Court of The Hague 14 October 2020 (Judge Knijff, Brinkman and Aalbers) [Dutch decision here]The second half of 2020 brought a remarkable decision in a case between health insurance company Menzis and pharmaceutical company AstraZeneca. [read post]
30 Jan 2008, 7:52 am
Three companies--Par Pharmaceuticals, Verizon Communications, and Aflacâ€â [read post]
2 Jul 2021, 11:39 pm by Kluwer Patent blogger
“The Annual Review 2020 shows that demand for European patents remained nearly on a par with last year. [read post]
25 Feb 2013, 11:29 am by Frank Pasquale
In a world where privately funded studies in areas ranging from pharmaceuticals to finance to climate science have come into question, autonomous forms of knowledge have value. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
31 May 2011, 8:38 pm by Marie Louise
Novo Nordisk (Orange Book Blog) Silenor (Doxepin) – US: Somaxon files patent infringement lawsuit against Par Pharmaceuticals over bid to market generic Silenor (GenericsWeb) Strattera (Atomoxetine) – US: Eli Lilly files patent infringement complaint against Zydus in response to Para IV certification (Patent Docs) Zemplar (Paricalcitol) – US: Abbott Lab’s files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs)… [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
24 Jun 2013, 6:08 am by Bradley Graveline
Par Pharmaceutical backed Paddock by agreeing to share the patent litigation costs if it obtained approval for its generic product. [read post]
24 Jun 2013, 10:08 am by Sheppard Mullin
Par Pharmaceutical backed Paddock by agreeing to share the patent litigation costs if it obtained approval for its generic product. [read post]
6 May 2008, 10:20 pm
 Falabella was fined approximately with U$8,000,000 and Almacenes París was fined U$5,000,000. [read post]